AiM Medical Robotics (Ft. Lauderdale, FL, USA) is developing the world’s first MRI compatible surgical robot. Our surgical robotic platform simultaneously combines surgical planning and procedure with MR functional robotics that provide precise trajectory guidance for neurosurgical procedures. As a Company, we aim to eliminate existing error and revision rates seen today, while reducing procedure time, to support better patient outcomes. Furthermore, our system is light weight, portable, and will significantly reduce hospital costs and provide a new level of surgical excellence for today’s neurosurgeon.

Therapeutic: Robotics

Artio Medical (Prairie Village, KS, US) is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and structural heart diseases.

Therapeutic: Cardiovascular, Interventional, Neurovascular, Hemodialysis

AseptiScope (San Diego, CA, USA) is a medical device start up founded in 2016. The company founders have introduced first in class clinical products in the past that remain standards of care. AseptiScope is focused on delivering first in class infection control technology that addresses the transmission potential for key vectors contributing to Healthcare Associated Infection (HAI). The flagship is The DiskCover System, the worlds first touch-free delivery system for single-use, aseptic disks to cover the stethoscope.

Therapeutic: Infection Control

CairnSurgical (Lebanon, NH) is a clinical stage company developing technology designed to improve surgical outcomes with image-derived, 3-D printed surgical guidance devices and interactive 3-D models. Our first product, the Breast Cancer Locator (BCL) is a proprietary patient-specific 3-D printed guide designed to enable precise tumor localization in the OR. The BCL also provides information regarding tumor size, shape, and clear margin boundary to help surgeons completely excise the cancer, reduce positive margin rates, and preserve normal breast tissue.

Therapeutic: Surgery, Women’s Health

Celero Systems (Lincoln, MA, USA) has developed and patented a long-acting physiological monitoring and drug delivery capsule. The smart capsule covers a range of enabling technologies including the ability to monitor physiology from inside the GI tract of a patient, and to respond to the detected physiology to treat a range of medical conditions. The capsule resides within the upper GI from 7 to 14 days and is cloud enabled allowing for physiological data to be shared with physicians resulting in improved patient care.

Therapeutic: Drug Delivery with Physiological Monitoring

Centese (Omaha, NE, USA) is driven to improve outcomes and reduce costs in cardiothoracic surgery. Thoraguard is a transformative digital medical device used in cardiac and thoracic surgery. The patented system integrates precision sensors, digital intelligence, and a one-of-a-kind design to improve patient outcomes, reduce costs, and provide surgeons with reliable data for better clinical decision making.

Therapeutic: Cardiovascular

Corvion (Houston, TX, USA) is a pre-clinical stage medical device company focused on bringing fully implanted heart assist technology to the worldwide market for mechanical circulatory support. By developing a highly efficient implantable rotary blood pump (3X more efficient than competitors) coupled with a robust and flexible transcutaneous (through the skin) charging technology, the company aims to dramatically improve patient outcomes and quality of life.

Therapeutic: Cardiovascular

Diality Inc. (Irvine, CA, USA) is a privately held medical device company developing a smart, flexible, portable hemodialysis machine that will enable patients to self-treat at home or wherever they travel. Diality is committed to improving the quality of life of patients with kidney disease and are developing a versatile hemodialysis solution that reduces the patient and caregiver burden of care and burnout, allowing more patients to benefit from their prescribed dialysis treatment at home or in a variety of care settings.

Therapeutic: Renal

Digital Diagnostics (Coralville, IA, USA) is an AI diagnostics company on a mission to benefit patients by transforming the accessibility, affordability, equity, and quality of global healthcare through the application of technology in the medical diagnosis and treatment process. The Company is paving the way for autonomous AI diagnosis to become a new standard of care, contributing to democratizing healthcare and closing care gaps.

Therapeutic: Artificial Intelligence & Diagnostics

DurVena (Danville, CA, USA) has developed a photochemical tissue passivation therapy (PTP) that strengthens venous tissue, reduces the inflammation that leads to hyperplasia of the vein’s intimal layer, and improves vein graft patency. DurVena is focusing PTP on improvement of vein graft patency in the CABG and PAD and maturation of AV Fistulas for hemodialysis. Combined these indications represent a $5B WW market.

Therapeutic: Cardiovascular, Surgery

EBR Systems (Sunnyvale, CA, USA) is overcoming the limitations of conventional pacemakers and CRT through Wireless, Left Ventricle, Endocardial Pacing.

Therapeutic: Cardiovascular

EndoShape (Boulder, CO, USA) is a venture-backed company seeking to improve embolization procedures for patients and physicians through the application of advanced polymer technology and unique device design. We are focused on the embolization and occlusion market and seek significant physician guidance as we engage in robust product development and commercialization activity. 

Therapeutic: Vascular

FAST BioMedical (Indianapolis, IN, USA) First in class globally patented technology that directly and accurately measures volume status (Plasma Volume). Initial target market is inpatient Heart Failure, where it can guide decongestion therapies. Late-clinical stage with five human trials complete. 30 months to commercialization.

Therapeutic: Cardiovascular

Genoskin is a Partner Research Organization (PRO) with unique expertise in skin and immunology disrupting subcutaneous drug development by changing the way we generate human data. The Genoskin team works with industry leaders in biotech and pharma to enable better, faster, and safer subcutaneous drug development via proprietary ex vivo human skin platforms. Genoskin's Injection Site Reaction platform has recently gained significant market traction with the growing trend of subcutaneous drug development.

Partner Research Organization

Description coming soon…

Therapeutic: Orthopedics — Spine

iCE Neurosystems (Washington, DC) developed the iCEWav platform to support doctors and nurses in the fight to save the brain during critical illness. Avoidable impacts of brain damage suffered during ICU care cost hospitals millions of dollars per year – and patients much more. iCEWav leverages patented FDA-cleared EEG devices, comprehensive brain/body data integration software and a cloud-based teleICU platform to solve the entire vertical of brain monitoring and optimize brain care for millions of critically ill patients per year.

Therapeutic: ICU-Critical Care, Neurology; Digital Biomarkers; Telemedicine

iDENTICAL (Mountain View, CA, USA) is revolutionizing tooth replacement with drill-free dental implants. By using 3D technology and our patent pending approach, we're able to make a dental implant that’s shaped almost identically to the patient's original tooth root. Within two weeks of a tooth extraction, a dentist can simply insert the iDENTICAL implant into the existing socketsite. Our drill-free solution is non-invasive, faster and more affordable than dental implants in the market today and can be provided by any dentist.

Therapeutic: Dental

Invenio Imaging, based in Santa Clara, CA has developed and manufactures the NIO Laser Imaging System. The NIO is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. Invenio recently received CE Mark to commercialise in Europe

Therapeutic: Imaging

Nia Therapeutics (Radnor, PA, USA) is developing the Smart Neurostimulation System for the treatment of memory loss. One in 12 Americans live with memory loss due to brain injury and neurodegenerative disease and no effective therapies are available. Our precision approach utilizes machine learning and neuroscience to personalize treatment to each patient, and we have demonstrated clinical proof of concept in neurosurgical patients. Nia’s near-term focus is to restore memory function in patients with traumatic brain injury, which affects over one million Americans.

Therapeutic: Neuromodulation-Neurostimulation, Cognitive rehabilitation

NE Scientific (Boston, MA, USA) Accublate simulates in real-time the physics taking place during the Radiofrequency and Microwave ablation of tumors. Computed temperatures are used to keep track and indicate on-screen, during the procedure, which part of the tumor is killed and which not. The goal of Accublate is to ensure the complete treatment of the tumor, a goal which, without similar tools, is missed today in 25% of cases for medium tumors, and in 58% of cases for large tumors.

Therapeutic: Interventional, Minimally Invasive, Thermal Ablation, Oncology

Novuson (Bothell, WA) is an innovative medical device company developing the world's first Direct Therapeutic Ultrasound (DTU) surgical instrument platform for minimally invasive, robotic and endoscopic surgeries. Novuson’s launch product (3mm Mini LS) is essential for Vessel Sealing/Dividing in Gynecological, Urological, Bariatric, Pediatric, Trauma, and other surgical specialties. Novuson holds 7 US patents and has filed in 6 countries internationally. The first product launch of the platform will be first-in-class 3mm Mini-Laparoscopic Sealer/Divider. Use of Novuson systems will improve safety, reduce bleeding, improve patient outcomes, and reduce hospital costs.

Therapeutic: Minimally Invasive Surgery, Electrosurgical Devices

nQ Medical (Cambridge, MA, USA) is a computational biotechnology company with a Digital Biomarker Discovery Platform that phenotypes neurodegenerative diseases through passive, AI-aided analysis of personal device interactions. Our biomarkers are used for early detection (years earlier than gold standard assessment tools), uses RWE to track disease progression over time, and because we track disease progression, we can measure the impact of therapy.

Therapeutic: Digital Biomarkers

Obsidio, Inc. (Sunnyvale, CA, USA) is pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels with broad applications in interventional radiology and interventional oncology.

Therapeutic: Cardiovascular, Therapeutic Embolization, Interventional Radiology, Interventional Oncology

Orthopedic Sciences (Seal Beach, CA, USA) is a privately held med-tech company founded in 1999 without prior debt or equity raises that currently holds 20 US patents for more than 80 devices in FDA Classes I and II. Our multitude of products are specifically designed for complete avoidance of a joint replacement. Notable products include the Bone Tool, the Hip Tool, The Beacon, to name a few.

Therapeutic: Orthopedics

Otolith Labs (Washington, DC, USA) Otolith is a wearable, FDA designated Breakthrough device for the treatment of chronic vertigo - a 5 million US patient Standard Of Care opportunity.

Therapeutic: ENT, Wearable, Vertigo

Description coming soon..

https://peerbridgehealth.com

Provisio Medical (San Diego, CA, USA) has developed a novel smart catheter technology, Sonic Lumen Tomography (SLT), that provides precise real-time flow lumen dimensions and can be integrated directly into the type of therapeutic catheters physicians are already using. Delivering the size and shape of a vessel lumen without the cost, time, and complexity of conventional endovascular imaging, Provisio’s SLT is designed to revolutionize interventional therapy by giving physicians the exact information that they need, when they need it, while improving workflow and outcomes.

Therapeutic: Interventional

RDS (Rhythm Diagnostic Systems, Strasbourg, France) MultiSense® is a wireless solution that monitors post-surgery vital-signs continuously, in the hospital and at home. It includes a small, adhesive electronic patch that is connected to a smartphone and collects physiological data, which is analyzed to derive actionable clinical-grade information. The MultiSense® patch measures ECG, heart rate, respiratory rate, oxygen saturation, skin temperature, activity, and posture continuously for 5+ days. The complete system will be marketed as a service to hospitals and other healthcare systems for post-surgery patient monitoring.

Therapeutic: Remote Patient Monitoring

Retia Medical (Valhalla, New York, USA) develops advanced algorithms for guiding the care of high-risk patients. Our first product, the Argos Hemodynamic Monitor, has FDA and CE Mark and is being sold in 14 countries. Customers include Johns Hopkins, Cleveland Clinic, Duke, NYP and several others. They chose the Argos because its accuracy is proven to be 50% better than the market leader, enabling it to be used consistently for more high-risk patients. Our team includes patient monitoring industry veterans with prior exits. We are raising $10M to accelerate sales.
Company Video

Therapeutic: Surgery, ICU-Critical Care

ReGelTec, Inc (Baltimore, MD, USA) is a clinical stage medical device company developing an innovative treatment for chronic lower back pain due to degenerative disc disease. HYDRAFIL™ is a proprietary hydrogel technology that can be injected percutaneously into the nucleus of an intervertebral disc to eliminate pain while maintaining structural stability and motion.

Therapeutic: Pain Management, Orthopedics, Spine

RIVANNA's (Charlottesville, VA,USA) world-first imaging-based medical technologies include BoneVision™ Multi-Probe Multi-Angle Image Acquisition, BoneEnhance® Multi-Frequency Image Reconstruction, and SpineNav3D™ AI-Enabled Spine Recognition. RIVANNA's complete clinician-assistance solutions improve decision-making, workflows, health outcomes, and patient satisfaction. RIVANNA is privately held and operates an FDA-registered and ISO 13485:2016 certified manufacturing facility.

Therapeutic: Imaging

SafKan Health's (Seattle, WA, USA) mission is to bring ear care into the 21st century. The leading cause of conductive hearing loss is impacted earwax, which affects 35 million Americans. Syringes, spray bottles, and dental flossers are time-consuming, messy, and antiquated. The company's OtoSet® Ear Cleaning System is the first automated and FDA cleared ear cleaning device. At the push of a button, liquid flow and micro-suction technology combine to automatically break down and remove impacted earwax for a quick, safe, effective, and mess-free procedure.

Therapeutic: ENT, Primary Care, Urgent Care, Audiology

***Description coming soon!

SpinTech MRI’s (Detroit, MI) STAGE imaging software platform enables comprehensive, quantitative, multi-contrast brain imaging with 40% faster scan times than conventional MRI. STAGE is compatible with existing equipment and provides standardized data across manufacturers. Running on top of this rich data is a suite of automated AI/ML biomarker detection and quantification tools, with extensive research validation in conditions including dementia, stroke, TBI, MS, Parkinson's, and tumors. STAGE is FDA 510K cleared and in use at over 60 top research sites globally.

Therapeutic: Imaging, Neurology

Unik Orthopedics (San Jose, CA, USA) leading-edge technologies combine personalization and a small portable bone-mounted surgical robot. Using imaging technologies, such as MRI/CT or X-rays, a customized bone registration guide is used during the procedure to position the robot on the patient’s anatomy based on a pre-determined anatomical reference. The bone registration process is instantaneous, highly accurate, and low cost. Subsequently, the surgeon can, in real-time, adjust the position, orientation and implant size for each individual patient during the procedure.

Therapeutic: Robotics, Orthopedics

Veriskin (San Diego, CA, USA) is a medical device company dedicated to facilitating and improving the accuracy of skin cancer screening. The TruScore is a proprietary, non-invasive, low-cost, hand-held device that aids a non-expert user to rapidly and objectively determine whether a suspect skin lesion is cancerous. Veriskin’s non-imaging based technology and AI algorithm work by using active, perturbative hemodynamic measurement to detect structural and functional vascular abnormalities associated with cancer-induced pathological angiogenesis which is a well-established hallmark of cancer.

Therpeutic: Diagnostics, Oncology